Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Handling Out-of-Specification Results

Posted on By

SOP for Handling Out-of-Specification Results

Standard Operating Procedure for Handling Out-of-Specification Results

1) Purpose

The purpose of this SOP is to establish procedures for the identification, investigation, and handling of out-of-specification (OOS) results to ensure product quality, data integrity, and compliance with regulatory requirements.

2) Scope

This SOP applies to all laboratory testing and manufacturing processes within the facility that may generate test results, including raw materials, in-process materials, and finished products.

3) Responsibilities

The responsibilities for this SOP are divided among various roles:

3.1 Quality Control (QC) Analyst:

Responsible for identifying and reporting OOS results during testing.

See also  SOP for Product Complaint Handling

3.2 Quality Assurance (QA) Specialist:

Responsible for overseeing the investigation and disposition of OOS results.

3.3 Production Supervisor:

Responsible for implementing corrective actions and preventing recurrence of OOS results.

4) Procedure

4.1 Identification of OOS Results:

4.1.1 Define OOS criteria and acceptance limits for each test.
4.1.2 Notify QA and Production Supervisor immediately upon identification of OOS results.
4.1.3 Secure and segregate the affected batch or sample for further investigation.

4.2 Investigation Process:

4.2.1 Form an investigation team including QC, QA, and Production representatives.
4.2.2 Conduct a thorough investigation to determine root cause(s) of the OOS result.
4.2.3 Document investigation findings and conclusions.

See also  SOP for Validation of Manufacturing Processes

4.3 Out-of-Specification Report:

4.3.1 Prepare an OOS report detailing investigation findings, root cause analysis, and corrective actions.
4.3.2 Obtain

approval of the OOS report from QA before proceeding with any corrective actions.
4.3.3 Communicate findings and actions to relevant stakeholders.

4.4 Corrective and Preventive Actions (CAPA):

4.4.1 Implement corrective actions to address identified root causes.
4.4.2 Develop preventive actions to prevent recurrence of OOS results.
4.4.3 Review and verify effectiveness of CAPA through follow-up and monitoring.

4.5 Documentation and Record Keeping:

4.5.1 Maintain accurate and complete records of all OOS investigations and actions taken.
4.5.2 Archive OOS records according to established document retention policies.
4.5.3 Provide OOS records during regulatory inspections and audits as required.

See also  SOP for Good Manufacturing Practices (GMP) Compliance

5) Abbreviations, if any

QC – Quality Control
QA – Quality Assurance

6) Documents, if any

1. OOS Investigation Report
2. Corrective and Preventive Action (CAPA) Plan
3. OOS Records
4. Training Records

7) Reference, if any

1. FDA Guidance for Industry: Investigating Out-of-Specification (OOS) Test Results for Pharmaceutical Production
2. ICH Q7 Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients

8) SOP Version

Version 1.0

Rectal Dosage Forms Tags:Enema preparation guidelines, GMP for rectal products, Rectal administration SOP, Rectal dosage batch record keeping, Rectal dosage change control procedure, Rectal dosage cleaning validation, Rectal dosage emergency response SOP, Rectal dosage environmental monitoring SOP, Rectal dosage facility sanitation SOP, Rectal dosage form stability testing SOP, Rectal dosage forms SOP, Rectal dosage GMP guidelines, Rectal dosage incident investigation procedure, Rectal dosage manufacturing procedures, Rectal dosage raw material handling SOP Rectal dosage equipment maintenance SOP, Rectal dosage risk management plan, Rectal dosage SOP templates, Rectal dosage sterilization SOP, Rectal dosage supplier qualification SOP, Rectal dosage testing procedures, Rectal drug delivery systems SOP, Rectal drug formulation SOP, Rectal enema preparation SOP, Rectal medication packaging SOP, Rectal product contamination control SOP, Rectal product documentation management, Rectal product inspection SOP, Rectal product labeling SOP, Rectal product quality control SOP, Rectal product storage SOP, Rectal suppository manufacturing guidelines, Suppository manufacturing SOP

Post navigation

Previous Post: SOP for GMP Compliance in Equipment Handling
Next Post: SOP for Validation Master Plan (VMP)

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version